{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:42:23Z","timestamp":1790959343097,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,11,2]],"date-time":"2014-11-02T00:00:00Z","timestamp":1414886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Histochem Cell Biol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00418-014-1292-0","type":"journal-article","created":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T22:37:01Z","timestamp":1414795021000},"page":"497-504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Co-expression of the homologous proteases fibroblast activation protein and dipeptidyl peptidase-IV in the adult human Langerhans islets"],"prefix":"10.1007","volume":"143","author":[{"given":"Petr","family":"Busek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Hrabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premysl","family":"Fric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksi","family":"Sedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,2]]},"reference":[{"key":"1292_CR1","doi-asserted-by":"crossref","first-page":"19441","DOI":"10.1074\/jbc.C500092200","volume":"280","author":"K Aertgeerts","year":"2005","unstructured":"Aertgeerts K et al (2005) Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. J Biol Chem 280:19441\u201319444","journal-title":"J Biol Chem"},{"key":"1292_CR2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.febslet.2008.02.005","volume":"582","author":"K Ajami","year":"2008","unstructured":"Ajami K et al (2008) Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8. FEBS Lett 582:819\u2013825","journal-title":"FEBS Lett"},{"key":"1292_CR4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11010-011-0828-z","volume":"354","author":"E Balaziova","year":"2011","unstructured":"Balaziova E, Busek P, Stremenova J, Sromova L, Krepela E, Lizcova L, Sedo A (2011) Coupled expression of dipeptidyl peptidase-IV and fibroblast activation protein-alpha in transformed astrocytic cells. Mol Cell Biochem 354:283\u2013289","journal-title":"Mol Cell Biochem"},{"key":"1292_CR5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/BJ20060079","volume":"396","author":"JR Bjelke","year":"2006","unstructured":"Bjelke JR, Christensen J, Nielsen PF, Branner S, Kanstrup AB, Wagtmann N, Rasmussen HB (2006) Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV. Biochem J 396:391\u2013399","journal-title":"Biochem J"},{"key":"1292_CR6","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/db09-1177","volume":"59","author":"D Bosco","year":"2010","unstructured":"Bosco D et al (2010) Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes 59:1202\u20131210. doi: 10.2337\/db09-1177","journal-title":"Diabetes"},{"key":"1292_CR7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1369\/jhc.5C6684.2005","volume":"53","author":"M Brissova","year":"2005","unstructured":"Brissova M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B, Harlan DM, Powers AC (2005) Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem 53:1087\u20131097. doi: 10.1369\/jhc.5C6684.2005","journal-title":"J Histochem Cytochem"},{"key":"1292_CR8","doi-asserted-by":"crossref","unstructured":"Busek P, Sedo A (2013) Dipeptidyl peptidase-IV and related proteases in brain tumors. In: Lichtor T (ed) Evolution of the molecular biology of brain tumors and the therapeutic implications. InTech. doi: 10.5772\/53888","DOI":"10.5772\/53888"},{"key":"1292_CR9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1357-2725(03)00262-0","volume":"36","author":"P Busek","year":"2004","unstructured":"Busek P, Malik R, Sedo A (2004) Dipeptidyl peptidase IV activity and\/or structure homologues (DASH) and their substrates in cancer. Int J Biochem Cell Biol 36:408\u2013421","journal-title":"Int J Biochem Cell Biol"},{"key":"1292_CR10","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.biocel.2012.01.011","volume":"44","author":"P Busek","year":"2012","unstructured":"Busek P et al (2012) Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity. Int J Biochem Cell Biol 44:738\u2013747. doi: 10.1016\/j.biocel.2012.01.011","journal-title":"Int J Biochem Cell Biol"},{"key":"1292_CR11","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/db12-1686","volume":"62","author":"AE Butler","year":"2013","unstructured":"Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, Butler PC (2013) Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 62:2595\u20132604. doi: 10.2337\/db12-1686","journal-title":"Diabetes"},{"key":"1292_CR12","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1073\/pnas.0510790103","volume":"103","author":"O Cabrera","year":"2006","unstructured":"Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A (2006) The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA 103:2334\u20132339. doi: 10.1073\/pnas.0510790103","journal-title":"Proc Natl Acad Sci USA"},{"key":"1292_CR13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MPA.0b013e31816618ce","volume":"37","author":"SJ Cohen","year":"2008","unstructured":"Cohen SJ et al (2008) Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. Pancreas 37:154\u2013158","journal-title":"Pancreas"},{"key":"1292_CR14","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1177\/37.12.2573631","volume":"37","author":"WN Dinjens","year":"1989","unstructured":"Dinjens WN, ten Kate J, van der Linden EP, Wijnen JT, Khan PM, Bosman FT (1989) Distribution of adenosine deaminase complexing protein (ADCP) in human tissues. J Histochem Cytochem 37:1869\u20131875","journal-title":"J Histochem Cytochem"},{"issue":"Suppl 2","key":"1292_CR15","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.2337\/dcS13-2015","volume":"36","author":"MY Donath","year":"2013","unstructured":"Donath MY, Burcelin R (2013) GLP-1 effects on islets: hormonal, neuronal, or paracrine? Diabetes Care 36(Suppl 2):S145\u2013S148. doi: 10.2337\/dcS13-2015","journal-title":"Diabetes Care"},{"key":"1292_CR16","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.2337\/db13-0822","volume":"62","author":"DJ Drucker","year":"2013","unstructured":"Drucker DJ (2013) Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls. Diabetes 62:3316\u20133323. doi: 10.2337\/db13-0822","journal-title":"Diabetes"},{"key":"1292_CR17","doi-asserted-by":"crossref","first-page":"29231","DOI":"10.1074\/jbc.M202770200","volume":"277","author":"G Ghersi","year":"2002","unstructured":"Ghersi G, Dong H, Goldstein LA, Yeh Y, Hakkinen L, Larjava HS, Chen WT (2002) Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex. J Biol Chem 277:29231\u201329241","journal-title":"J Biol Chem"},{"key":"1292_CR18","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1158\/0008-5472.CAN-05-1245","volume":"66","author":"G Ghersi","year":"2006","unstructured":"Ghersi G, Zhao Q, Salamone M, Yeh YY, Zucker S, Chen WT (2006) The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices. Cancer Res 66:4652\u20134661","journal-title":"Cancer Res"},{"key":"1292_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0925-4439(97)00032-X","volume":"1361","author":"LA Goldstein","year":"1997","unstructured":"Goldstein LA, Ghersi G, Pineiro-Sanchez ML, Salamone M, Yeh Y, Flessate D, Chen WT (1997) Molecular cloning of seprase: a serine integral membrane protease from human melanoma. Biochim Biophys Acta 1361:11\u201319","journal-title":"Biochim Biophys Acta"},{"key":"1292_CR3","unstructured":"Gorrell MD et al (2014) DPP4 and FAP in glucose and lipid metabolism and liver injury in mice. In: Australian Diabetes Society and Australian Diabetes Educators Association, Melbourne Convention and Exhibition Centre, 27th-29th August 2014, abstract 18"},{"key":"1292_CR20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000151741","volume":"75","author":"MA Goscinski","year":"2008","unstructured":"Goscinski MA et al (2008) Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China. Oncology 75:49\u201359","journal-title":"Oncology"},{"key":"1292_CR21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/002215549904700407","volume":"47","author":"G Grondin","year":"1999","unstructured":"Grondin G, Hooper NM, LeBel D (1999) Specific localization of membrane dipeptidase and dipeptidyl peptidase IV in secretion granules of two different pancreatic islet cells. J Histochem Cytochem 47:489\u2013498","journal-title":"J Histochem Cytochem"},{"key":"1292_CR22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/prca.201300095","volume":"8","author":"EJ Hamson","year":"2014","unstructured":"Hamson EJ, Keane FM, Tholen S, Schilling O, Gorrell MD (2014) Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. PROTEOMICS Clin Appl 8:454\u2013463. doi: 10.1002\/prca.201300095","journal-title":"PROTEOMICS Clin Appl"},{"key":"1292_CR23","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/endo.140.11.7143","volume":"140","author":"L Hansen","year":"1999","unstructured":"Hansen L, Deacon CF, Orskov C, Holst JJ (1999) Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 140:5356\u20135363. doi: 10.1210\/endo.140.11.7143","journal-title":"Endocrinology"},{"key":"1292_CR24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.clpt.2005.09.002","volume":"78","author":"GA Herman","year":"2005","unstructured":"Herman GA et al (2005) Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses. Clin Pharmacol Ther 78:675\u2013688. doi: 10.1016\/j.clpt.2005.09.002","journal-title":"Clin Pharmacol Ther"},{"key":"1292_CR25","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1074\/jbc.275.6.3827","volume":"275","author":"SA Hinke","year":"2000","unstructured":"Hinke SA et al (2000) Dipeptidyl peptidase IV (DPIV\/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs. J Biol Chem 275:3827\u20133834","journal-title":"J Biol Chem"},{"key":"1292_CR26","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1210\/en.2007-0404","volume":"148","author":"Y Imai","year":"2007","unstructured":"Imai Y, Patel HR, Hawkins EJ, Doliba NM, Matschinsky FM, Ahima RS (2007) Insulin secretion is increased in pancreatic islets of neuropeptide Y-deficient mice. Endocrinology 148:5716\u20135723. doi: 10.1210\/en.2007-0404","journal-title":"Endocrinology"},{"key":"1292_CR27","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1158\/1078-0432.CCR-07-0110","volume":"13","author":"T Inamoto","year":"2007","unstructured":"Inamoto T et al (2007) Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors. Clin Cancer Res 13:4191\u20134200. doi: 10.1158\/1078-0432.ccr-07-0110","journal-title":"Clin Cancer Res"},{"key":"1292_CR28","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2174\/156652412803833607","volume":"12","author":"M Jacob","year":"2012","unstructured":"Jacob M, Chang L, Pure E (2012) Fibroblast activation protein in remodeling tissues. Curr Mol Med 12:1220\u20131243","journal-title":"Curr Mol Med"},{"key":"1292_CR29","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn SE, Cooper ME, Del Prato S (2014) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383:1068\u20131083. doi: 10.1016\/S0140-6736(13)62154-6","journal-title":"Lancet"},{"key":"1292_CR30","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1742-4658.2011.08051.x","volume":"278","author":"FM Keane","year":"2011","unstructured":"Keane FM, Nadvi NA, Yao TW, Gorrell MD (2011) Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-alpha. FEBS J 278:1316\u20131332","journal-title":"FEBS J"},{"key":"1292_CR31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/jm0493156","volume":"48","author":"D Kim","year":"2005","unstructured":"Kim D et al (2005) (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)- yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem 48:141\u2013151. doi: 10.1021\/jm0493156","journal-title":"J Med Chem"},{"key":"1292_CR32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12031-012-9752-2","volume":"48","author":"DS Koh","year":"2012","unstructured":"Koh DS, Cho JH, Chen L (2012) Paracrine interactions within islets of Langerhans. J Mol Neurosci 48:429\u2013440. doi: 10.1007\/s12031-012-9752-2","journal-title":"J Mol Neurosci"},{"key":"1292_CR33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","volume":"40","author":"AM Lambeir","year":"2003","unstructured":"Lambeir AM, Durinx C, Scharpe S, De Meester I (2003) Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 40:209\u2013294","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1292_CR34","first-page":"137","volume":"131","author":"V Lichnovsky","year":"1991","unstructured":"Lichnovsky V, Lojda Z, Bocek M (1991) Distribution of the activity of some peptidases in the pancreas of human embryo. Acta Univ Palacki Olomuc Fac Med 131:137\u2013143","journal-title":"Acta Univ Palacki Olomuc Fac Med"},{"key":"1292_CR35","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00125-011-2181-x","volume":"54","author":"Z Liu","year":"2011","unstructured":"Liu Z, Stanojevic V, Avadhani S, Yano T, Habener JF (2011) Stromal cell-derived factor-1 (SDF-1)\/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival. Diabetologia 54:2067\u20132076. doi: 10.1007\/s00125-011-2181-x","journal-title":"Diabetologia"},{"key":"1292_CR36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/29.3.481","volume":"29","author":"Z Lojda","year":"1981","unstructured":"Lojda Z (1981) Proteinases in pathology. Usefulness of histochemical methods. J Histochem Cytochem 29:481\u2013493","journal-title":"J Histochem Cytochem"},{"key":"1292_CR37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejim.2014.03.005","volume":"25","author":"A Lund","year":"2014","unstructured":"Lund A, Knop FK, Vilsboll T (2014) Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities. Eur J Intern Med 25:407\u2013414. doi: 10.1016\/j.ejim.2014.03.005","journal-title":"Eur J Intern Med"},{"key":"1292_CR38","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.2337\/db10-1532","volume":"60","author":"V Lyssenko","year":"2011","unstructured":"Lyssenko V et al (2011) Pleiotropic effects of GIP on islet function involve osteopontin. Diabetes 60:2424\u20132433. doi: 10.2337\/db10-1532","journal-title":"Diabetes"},{"key":"1292_CR39","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1007\/s00125-012-2716-9","volume":"55","author":"P Marchetti","year":"2012","unstructured":"Marchetti P et al (2012) A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia 55:3262\u20133272. doi: 10.1007\/s00125-012-2716-9","journal-title":"Diabetologia"},{"key":"1292_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(99)00089-0","volume":"85","author":"R Mentlein","year":"1999","unstructured":"Mentlein R (1999) Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 85:9\u201324","journal-title":"Regul Pept"},{"key":"1292_CR41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/44.5.8627002","volume":"44","author":"S Mentzel","year":"1996","unstructured":"Mentzel S, Dijkman HB, Van Son JP, Koene RA, Assmann KJ (1996) Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice. J Histochem Cytochem 44:445\u2013461","journal-title":"J Histochem Cytochem"},{"key":"1292_CR42","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s00125-014-3299-4","volume":"57","author":"BA Omar","year":"2014","unstructured":"Omar BA, Liehua L, Yamada Y, Seino Y, Marchetti P, Ahren B (2014) Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes. Diabetologia 57:1876\u20131883. doi: 10.1007\/s00125-014-3299-4","journal-title":"Diabetologia"},{"key":"1292_CR43","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/en.2002-220371","volume":"143","author":"K Persson","year":"2002","unstructured":"Persson K, Pacini G, Sundler F, Ahren B (2002) Islet function phenotype in gastrin-releasing peptide receptor gene-deficient mice. Endocrinology 143:3717\u20133726. doi: 10.1210\/en.2002-220371","journal-title":"Endocrinology"},{"key":"1292_CR44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0167-0115(00)00170-1","volume":"96","author":"JA Pospisilik","year":"2001","unstructured":"Pospisilik JA et al (2001) Metabolism of glucagon by dipeptidyl peptidase IV (CD26). Regul Pept 96:133\u2013141","journal-title":"Regul Pept"},{"key":"1292_CR45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/41.1.8093256","volume":"41","author":"MD Poulsen","year":"1993","unstructured":"Poulsen MD, Hansen GH, Dabelsteen E, Hoyer PE, Noren O, Sjostrom H (1993) Dipeptidyl peptidase IV is sorted to the secretory granules in pancreatic islet A-cells. J Histochem Cytochem 41:81\u201388","journal-title":"J Histochem Cytochem"},{"key":"1292_CR46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmet.2011.05.008","volume":"14","author":"R Rodriguez-Diaz","year":"2011","unstructured":"Rodriguez-Diaz R, Abdulreda MH, Formoso AL, Gans I, Ricordi C, Berggren PO, Caicedo A (2011) Innervation patterns of autonomic axons in the human endocrine pancreas. Cell Metab 14:45\u201354. doi: 10.1016\/j.cmet.2011.05.008","journal-title":"Cell Metab"},{"key":"1292_CR47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.gastro.2012.04.047","volume":"143","author":"AH Sam","year":"2012","unstructured":"Sam AH et al (2012) Selective ablation of peptide YY cells in adult mice reveals their role in beta cell survival. Gastroenterology 143:459\u2013468. doi: 10.1053\/j.gastro.2012.04.047","journal-title":"Gastroenterology"},{"key":"1292_CR48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-4838(01)00278-3","volume":"1550","author":"A Sedo","year":"2001","unstructured":"Sedo A, Malik R (2001) Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities? Biochim Biophys Acta 1550:107\u2013116","journal-title":"Biochim Biophys Acta"},{"key":"1292_CR49","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1096\/fasebj.9.9.7601338","volume":"9","author":"G Vanhoof","year":"1995","unstructured":"Vanhoof G, Goossens F, De Meester I, Hendriks D, Scharpe S (1995) Proline motifs in peptides and their biological processing. FASEB J 9:736\u2013744","journal-title":"FASEB J"},{"key":"1292_CR50","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1210\/en.2011-0286","volume":"152","author":"A Waget","year":"2011","unstructured":"Waget A et al (2011) Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice. Endocrinology 152:3018\u20133029. doi: 10.1210\/en.2011-0286","journal-title":"Endocrinology"},{"key":"1292_CR51","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2337\/diab.38.3.338","volume":"38","author":"GC Weir","year":"1989","unstructured":"Weir GC, Mojsov S, Hendrick GK, Habener JF (1989) Glucagonlike peptide I (7-37) actions on endocrine pancreas. Diabetes 38:338\u2013342","journal-title":"Diabetes"},{"key":"1292_CR52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.190.3.311","volume":"190","author":"UV Wesley","year":"1999","unstructured":"Wesley UV, Albino AP, Tiwari S, Houghton AN (1999) A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med 190:311\u2013322","journal-title":"J Exp Med"},{"key":"1292_CR53","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/ijc.20091","volume":"109","author":"UV Wesley","year":"2004","unstructured":"Wesley UV, Tiwari S, Houghton AN (2004) Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells. Int J Cancer 109:855\u2013866","journal-title":"Int J Cancer"},{"key":"1292_CR54","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.peptides.2007.04.024","volume":"28","author":"MS Winzell","year":"2007","unstructured":"Winzell MS, Ahren B (2007) Role of VIP and PACAP in islet function. Peptides 28:1805\u20131813. doi: 10.1016\/j.peptides.2007.04.024","journal-title":"Peptides"}],"container-title":["Histochemistry and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-014-1292-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00418-014-1292-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-014-1292-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T18:32:34Z","timestamp":1565980354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00418-014-1292-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,2]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1292"],"URL":"https:\/\/doi.org\/10.1007\/s00418-014-1292-0","relation":{},"ISSN":["0948-6143","1432-119X"],"issn-type":[{"value":"0948-6143","type":"print"},{"value":"1432-119X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,2]]}}}